Arava en es it fr

Arava Brand names, Arava Analogs

Arava Brand Names Mixture

  • No information avaliable

Arava Chemical_Formula


Arava RX_link

Arava fda sheet

Arava FDA

Arava msds (material safety sheet)

Arava MSDS

Arava Synthesis Reference

No information avaliable

Arava Molecular Weight

270.207 g/mol

Arava Melting Point

165-166 oC

Arava H2O Solubility

21 mg/L (poorly soluble)

Arava State


Arava LogP


Arava Dosage Forms


Arava Indication

For the treatment of active rheumatoid arthritis (RA).

Arava Pharmacology

Leflunomide is a pyrimidine synthesis inhibitor indicated in adults for the treatment of active rheumatoid arthritis (RA). RA is an auto-immune disease characterized by high T-cell activity. T cells have two pathways to synthesize pyrimidines: the salvage pathways and the de novo synthesis. At rest, T lymphocytes meet their metabolic requirements by the salvage pathway. Activated lymphocytes need to expand their pyrimidine pool 7- to 8-fold, while the purine pool is expanded only 2- to 3-fold. To meet the need for more pyrimidines, activated T cells use the de novo pathway for pyrimidine synthesis. Therefore, activated T cells, which are dependent on de novo pyrimidine synthesis, will be more affected by leflunomide's inhibition of dihydroorotate dehydrogenase than other cell types that use the salvage pathway of pyrimidine synthesis.

Arava Absorption

Well absorbed, peak plasma concentrations appear 6-12 hours after dosing

Arava side effects and Toxicity

LD50=100-250 mg/kg (acute oral toxicity)

Arava Patient Information

No information avaliable

Arava Organisms Affected

Humans and other mammals